MA53346A - Composition de vaccin muqueux pour la mastite bovine - Google Patents

Composition de vaccin muqueux pour la mastite bovine

Info

Publication number
MA53346A
MA53346A MA053346A MA53346A MA53346A MA 53346 A MA53346 A MA 53346A MA 053346 A MA053346 A MA 053346A MA 53346 A MA53346 A MA 53346A MA 53346 A MA53346 A MA 53346A
Authority
MA
Morocco
Prior art keywords
mucous
vaccine composition
bovine mastitis
mastitis
bovine
Prior art date
Application number
MA053346A
Other languages
English (en)
Inventor
Kazunari Akiyoshi
Hisashi Aso
Tomohito Hayashi
Yoshio KIKU
Yuya NAGASAWA
Tomonori Nochi
Shin-Ichi Sawada
Original Assignee
Univ Kyoto
Nat Agriculture & Food Res Org
Univ Tohoku
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Kyoto, Nat Agriculture & Food Res Org, Univ Tohoku filed Critical Univ Kyoto
Publication of MA53346A publication Critical patent/MA53346A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/085—Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5161—Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55583—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6087—Polysaccharides; Lipopolysaccharides [LPS]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pregnancy & Childbirth (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Microbiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Inorganic Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
MA053346A 2018-08-03 2019-08-02 Composition de vaccin muqueux pour la mastite bovine MA53346A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2018147175A JP2020019754A (ja) 2018-08-03 2018-08-03 ウシ乳房炎に対する粘膜ワクチン組成物

Publications (1)

Publication Number Publication Date
MA53346A true MA53346A (fr) 2022-04-27

Family

ID=69231804

Family Applications (1)

Application Number Title Priority Date Filing Date
MA053346A MA53346A (fr) 2018-08-03 2019-08-02 Composition de vaccin muqueux pour la mastite bovine

Country Status (6)

Country Link
US (1) US20210322531A1 (fr)
EP (1) EP3831405A4 (fr)
JP (1) JP2020019754A (fr)
CN (1) CN112533631A (fr)
MA (1) MA53346A (fr)
WO (1) WO2020027318A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022210465A1 (fr) * 2021-03-30 2022-10-06 国立大学法人東京大学 Vaccin enrobé de nanogel
CN114306237A (zh) * 2022-01-06 2022-04-12 江苏爱朋医疗科技股份有限公司 一种鼻腔护理喷雾剂及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000012564A1 (fr) 1998-08-31 2000-03-09 Nof Corporation Polysaccharide a haut degre de purete contenant des groupes hydrophobes et procede de production de ce polysaccharide
JP2009286730A (ja) 2008-05-29 2009-12-10 Nai Kk 新規乳房炎ワクチン
JP5344558B2 (ja) * 2008-10-31 2013-11-20 国立大学法人 東京医科歯科大学 カチオン性ナノゲルを用いる粘膜ワクチン
WO2014054588A1 (fr) 2012-10-01 2014-04-10 国立大学法人京都大学 Complexe nanogel-exosome et mode d'administration
JP6310720B2 (ja) 2014-02-17 2018-04-11 知的財産戦略ネットワーク株式会社 肺炎球菌経鼻ワクチン

Also Published As

Publication number Publication date
CN112533631A (zh) 2021-03-19
EP3831405A1 (fr) 2021-06-09
JP2020019754A (ja) 2020-02-06
EP3831405A4 (fr) 2022-04-27
US20210322531A1 (en) 2021-10-21
WO2020027318A1 (fr) 2020-02-06

Similar Documents

Publication Publication Date Title
MA54714A (fr) Formulation de nicotine
MA53544A (fr) Procédé de préparation de compositions de vaccin
EA201891489A1 (ru) Фармацевтическая композиция, содержащая аморфный леналидомид и антиоксидант
SG11202010821TA (en) Vaccine composition
MA43587A (fr) Arnm thérapeutiques codant pour des anticorps anti-ctla-4
ES2974693T3 (es) Sistema de implante dental mejorado
FR3027521B1 (fr) Compositions pour administration par voie orale
MA43800A (fr) Octréotide par voie orale pour le traitement de maladies
EP3823666A4 (fr) Formulations de vaccin comprenant un système conservateur
GB201802339D0 (en) Immunogenic composition
MA54234A (fr) Implant dentaire
DK3873362T3 (da) Kirurgisk indretning til implantatfjernelse
MA53346A (fr) Composition de vaccin muqueux pour la mastite bovine
SG11202009147UA (en) Vaccine compositions
DK3274447T3 (da) Rekombinant fåresygevirus jeryl lynn 2 baseret vaccine
IL283802A (en) Protein preparations with a high concentration to prevent tissue adhesion
SG11202103389WA (en) Immunogenic compositions
PT3632436T (pt) Composição farmacêutica compreendendo sais de lenvatinib
MA53131A (fr) Composition immunogène pour la paratuberculose
DK3908321T3 (da) Farmaceutisk sammensætning
DK3773501T3 (da) Intravaginal formulering
DK3781132T3 (da) Apixabanformuleringer
DK3763212T3 (da) Artropoda-afvisende sammensætning
DK3752598T3 (da) Allogen sammensætning
MA51826A (fr) Compositions pharmaceutiques comprenant de la teixobactine